581 followers
mega-analyses of prospective trials: AD monotherapy demonstrated greater short-term symptom reduction on HRSD scores vs lithium in patients with BD-II (b= −2.33, p<0.0001). No differences were observed in change over time for YMR scores (b=0.06, p = 0.…